CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Craig Hallum from $15.00 to $20.00. They now have a "buy" rating on the stock.
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Lake Street Capital from $12.00 to $15.00. They now have a "buy" rating on the stock.